Who is sponsoring NCT04959721?

NCT04959721 is sponsored by Min Cheol Chang.

What drugs are being tested in NCT04959721?

Interventions in NCT04959721: Injection with triamcinolone acetonide, bupivacaine, and normal saline.

What condition does NCT04959721 study?

NCT04959721 studies Cervical Facet Joint Pain.

Is NCT04959721 still recruiting?

NCT04959721 is currently status unknown. Last updated 13 July 2021.

Last reviewed 2021-07-13 · How we verify

NCT04959721

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment for Whiplash Injury

Status unknown NA Last updated 13 July 2021

What this trial tests

NA trial testing Injection with triamcinolone acetonide, bupivacaine, and normal saline in Cervical Facet Joint Pain in 32 participants. Status unknown.

Timeline

15 July 2021

Primary endpoint
15 September 2021

15 October 2021

Quick facts

Lead sponsor	Min Cheol Chang
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	32
Start date	15 July 2021
Primary completion	15 September 2021
Estimated completion	15 October 2021
Sites	1 location across South Korea

Drugs / interventions tested

Injection with triamcinolone acetonide, bupivacaine, and normal saline

Conditions studied

Cervical Facet Joint Pain — all drugs for Cervical Facet Joint Pain →

Sponsor

Min Cheol Chang

Who can join

Adults 20 to 79, any sex, with Cervical Facet Joint Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: Cervical facet joint (CFJ) pain is commonly seen after whiplash injuries, and is frequently refractory to physical therapy and oral medication. The investigators will evaluate the effectiveness of intra-articular corticosteroid injection for managing whiplash-related CFJ pain. Methods: The investigators will recruit 32 patients with chronic and persistent CFJ pain (≥ 3 on the Numeric Rating Scale \[NRS\]) despite physical therapy and oral medication. Under fluoroscopy guidance, The investigators will inject 10 mg (0.25 mL) of triamcinolone acetonide, mixed with 0.25 mL of 0.125% bupivacaine and 0.5 mL of normal saline. At 1 and 2 months after the injection, pain intensity will be reassessed using the NRS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cervical Facet Joint Pain

Currently open trials in the same condition.

NCT05424198 — Trident Multi-tined Cannula for Cervical MBRFA Compared to the Conventional Cannula · NA · recruiting
NCT05450679 — Cervical Paraspinal Muscle Twitching and Cervical Facet Radiofrequency Ablation Outcomes · active not recruiting

Other Min Cheol Chang trials

Trials by the same sponsor.

NCT04833660 — rTMS on Diabetic Peripheral Neuropathic Pain · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04959721 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Min Cheol Chang
Last refreshed: 13 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04959721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing